These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19751258)

  • 1. Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2010 Dec; 106(11):1681-5. PubMed ID: 19751258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.
    Liu HT; Tyagi P; Chancellor MB; Kuo HC
    BJU Int; 2009 Nov; 104(10):1476-81. PubMed ID: 19522864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders.
    Mukerji G; Waters J; Chessell IP; Bountra C; Agarwal SK; Anand P
    BMC Urol; 2006 Dec; 6():31. PubMed ID: 17192176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.
    Kim JC; Park EY; Hong SH; Seo SI; Park YH; Hwang TK
    Int J Urol; 2005 Oct; 12(10):875-80. PubMed ID: 16323980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary nerve growth factor level could be a biomarker in the differential diagnosis of mixed urinary incontinence in women.
    Liu HT; Chancellor MB; Kuo HC
    BJU Int; 2008 Nov; 102(10):1440-4. PubMed ID: 18489524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamics for the evaluation of painful bladder syndrome/interstitial cystitis.
    Blaivas JG
    J Urol; 2010 Jul; 184(1):16-7. PubMed ID: 20488492
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.
    Liu HT; Kuo HC
    Neurourol Urodyn; 2009; 28(1):78-81. PubMed ID: 19089891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder.
    Chung SD; Liu HT; Lin H; Kuo HC
    Neurourol Urodyn; 2011 Mar; 30(3):417-20. PubMed ID: 21284020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder.
    Liu HT; Kuo HC
    J Urol; 2008 Jun; 179(6):2270-4. PubMed ID: 18423678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection.
    Liu HT; Chancellor MB; Kuo HC
    Eur Urol; 2009 Oct; 56(4):700-6. PubMed ID: 18472208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients.
    Jacobs BL; Smaldone MC; Tyagi V; Philips BJ; Jackman SV; Leng WW; Tyagi P
    Can J Urol; 2010 Feb; 17(1):4989-94. PubMed ID: 20156378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential factors that can be used to differentiate between interstitial cystitis/painful bladder syndrome and bladder oversensitivity in women.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2012 Feb; 66(2):146-51. PubMed ID: 21951755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder.
    Liu HT; Chancellor MB; Kuo HC
    BJU Int; 2009 Jun; 103(12):1668-72. PubMed ID: 19220267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident.
    Liu HT; Liu AB; Chancellor MB; Kuo HC
    BJU Int; 2009 Oct; 104(8):1158-62. PubMed ID: 19338537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder.
    Yokoyama T; Kumon H; Nagai A
    Neurourol Urodyn; 2008; 27(5):417-20. PubMed ID: 17924444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics for the evaluation of painful bladder syndrome/interstitial cystitis.
    Payne C
    J Urol; 2010 Jul; 184(1):15-6. PubMed ID: 20478598
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.
    Liu HT; Kuo HC
    Urology; 2008 Jul; 72(1):104-8; discussion 108. PubMed ID: 18400272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary nerve growth factor correlates with the severity of urgency and pain.
    Kim SW; Im YJ; Choi HC; Kang HJ; Kim JY; Kim JH
    Int Urogynecol J; 2014 Nov; 25(11):1561-7. PubMed ID: 24866276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.
    Lee SR; Hong CH; Choi YD; Kim JH
    J Urol; 2010 Jun; 183(6):2440-4. PubMed ID: 20403616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
    Kim SH; Kim TB; Kim SW; Oh SJ
    J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.